Skip to content

SHINE: Trends and Satisfaction in Hypertensives Using Aktiia Optical BP Monitoring Device (SHINE)

SHINE Study: Blood Pressure Evolution and User Satisfaction in a Hypertensive Population Using the Aktiia 24/7 Optical Blood Pressure Monitoring (OBPM) Device: a Prospective Observational Cohort Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06356077
Acronym
SHINE
Enrollment
1729
Registered
2024-04-10
Start date
2024-07-31
Completion date
2025-04-30
Last updated
2025-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

The SHINE study aims to gather data on the evolution of participant's blood pressure and to correlate this with demographic, lifestyle and health factors in a hypertensive population as well as, to gather data on participants' perception of the device under test (Aktiia 24/7).

Interventions

None listed

Sponsors

Lindus Health
CollaboratorINDUSTRY
Aktiia SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Adult participants aged 22 to 85 years old 2. A participant whose last blood pressure reading was within the last 12 months and was either: 1. SBP ≥145 2. or ≥DBP 90 3. People who use either an iOS or Android smartphone 4. People who have 2 arms 5. Able and willing to provide informed consent and to adhere to study procedures.

Exclusion criteria

1. Participants whose BP data submitted is \>180 mm Hg systolic OR \>120 mm Hg diastolic . 2. Participants with a self-reported known diagnosis of 1. atrial fibrillation 2. congestive heart failure 3. heart valve disease 4. pheochromocytoma 5. Raynaud's disease 6. arm lymphedema 3. Participants who take insulin 4. Participants who are on hemodialysis 5. Women who are self-reported to be pregnant 6. Participants whose arms shake uncontrollably or are paralyzed (cannot move) 7. Participants with upper arm circumference \<22 cm or \>42 cm 8. Participants with wrist circumference \>23cm 9. Participation in another interventional clinical study or use of investigational drugs in the last 30 days.

Design outcomes

Primary

MeasureTime frameDescription
Blood Pressure evolution over 12 weeks3 monthsMeans, medians, standard deviations, and ranges for Blood Pressure readings and changes in Blood Pressure readings within the study population between week 1 to week 12.

Secondary

MeasureTime frameDescription
Preferences of subjects regarding the method to monitor their blood pressure between Aktiia Bracelet, Home Blood Pressure Monitor, or Ambulatory Blood Pressure Monitor3 monthsNumber of participants with preferences using Aktiia 24/7 device, as copared to Home Blood Pressure Monitor, or Ambulatory Blood Pressure Monitor to monitor their blood pressure.
Correlation between the data from Aktiia 24/7 device continual BP monitoring with sociodemographic, lifestyle and health factors.3 monthsStatistics on a potential correlation between Blood Pressure measurements and subjects responses to questionnaires regarding their lifestyle, socioeconomic environment and general health.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026